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Abstract
Background and Aims: The EpiCom study and inception cohort was initiated in 2010 in 31 centers
from 14 Western and 8 Eastern European countries, covering a 10.1 million person background
population. Our aim was to investigate whether there is a difference between Eastern and
Western Europe in health care and education of patients with inflammatory bowel disease (IBD). 3, 2016Methods: A quality of care (QoC) questionnaire was developed in the EpiCom group consisting of
16 questions covering 5 items: time interval between the onset of symptoms and diagnosis,
information, education, empathy and access to health care providers.
Results: Of 1,515 patients, 947 (217 east/730 west) answered the QoC questionnaire. Only 23%
of all patients had knowledge about IBD before diagnosis. In Eastern Europe, significantly more
patients searched out information about IBD themselves (77% vs. 68%, p b 0.05), the main source
was the Internet (92% vs. 88% p = 0.23). In Western Europe, significantly more patients were
educated by nurses (19% vs. 1%, p b 0.05), while in Eastern Europe, gastroenterologists were
easier to contact (80% vs. 68%, p b 0.05).
Conclusion: Health care differed significantly between Eastern and Western Europe in all items,
but satisfaction rates were high in both geographic regions. Because of the low awareness and
the rising incidence of IBD, general information should be the focus of patient organizations and
medical societies. In Western Europe IBD nurses play a very important role in reducing the
burden of patient management.
© 2014 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.1. Introduction
The incidence of the two entities of inflammatory bowel
disease (IBD), Crohn's disease (CD) and ulcerative colitis (UC)is twice as high in Western European countries as in Eastern
European countries.1 It primarily affects young adults; the
highest prevalence is observed between the ages of 20 and
40 years. As IBD is a chronic, lifelong condition, patients
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 require frequent contact with the health care system and
regular follow-up at outpatient clinics. Quality of care (QoC)
was defined by the Institute of Medicine in 1990 as “the
degree to which health services for individuals and popula-
tions increase the likelihood of desired health outcomes, and
are consistent with current professional knowledge.”2
QoC plays an important role in the life of patients with this
chronic disorder, and it also influences their health-related
quality of life (HRQoL).3 To define IBD patients' needs in QoC in
Europe, a European Crohn's and Colitis Organization (ECCO)
consensus was developed in 2008. Optimizing QoC by informa-
tion, education, benchmarking and psychological analysis helps
the patients to cope with their condition and improves their
HRQoL and compliance with medical therapy.4 The ECCO
Epidemiological Committee (EpiCom) cohort is a prospective,
population-based inception cohort of IBD patients from 31
centers in 14 Western and 8 Eastern European countries
covering a 10.1 million person background population.5 The
aim of our present study was to assess the differences between
Eastern andWestern Europe in health care and education of IBD
patients in the ECCO-EpiCom inception cohort.
2. Materials and methods
2.1. Study population
In the ECCO-EpiCom inception cohort, 1,515 IBD patients aged
15 years or older recruited from a background population
of 10.1 million were diagnosed between 1 January and 31
December 2010; 256 patients (17%) from Eastern Europe and
1,259 (83%) from Western Europe. Cases were required to
fulfill the Copenhagen Diagnostic Criteria for UC,6 CD7 and
IBDU.1,8 Disease behavior and location of CD and extent of UC
were defined according to the Montreal classification.9 Data
regarding patients' demographics, disease characteristics and
treatment were entered into aWeb-based EpiComdatabase at
diagnosis and every third month during the follow-up period.
2.2. EpiCom quality of care questionnaire
To describe the conditions regarding the level of health care
and education of IBD patients, a QoC questionnaire was
constructed by IBD nurses in the EpiCom group on the basis of
the ECCO consensus4 about IBD patients' needs in quality of
health care (see Table S1). The questionnaire consisted of 16
questions with 5 care dimensions: two questions regarding the
time interval between the onset of symptoms and diagnosis,
patients' and doctors' delay and the time elapsed between the
first consultation at the general practitioner and time at which
the patients were referred to a gastroenterologist.
There were six questions concerning the patients'
knowledge about their disease before and after diagnosis,
the sources of information in the health care system and
patient self-searching information. Information about IBD
means in this case a general knowledge about the disease—
the pathogenesis and prevalence of IBD, among others.
In three questions, patients were asked about whether they
received education about IBD. This item implicates all methods
and how patients were taught about disease-specific coping
mechanisms. Four questions about empathy refer to the
courtesy of themembers of the health care system andwhetherthey were felt to spend enough time with the patients and
answer their questions adequately. One question concerned the
access to health care providers: patients had to identify which
member of their IBD staff was the easiest to reach.
2.3. Statistical considerations
All statistical analyses were carried out using SPSS software
Version 19.0 for Windows (SPSS Inc., Chicago, IL). Standard
descriptive statistics was performed, including frequency
distributions for categorical data and calculation of median
and range for continuous variables. Differences between
groups were analysed by Chi-Square test for categorical data.
A p value of b0.05 was considered statistically significant.
2.4. Ethical statement
The study was approved by the local ethics committees
according to local regulations. All subjects gave written
informed consent prior to answering the questionnaire.
3. Results
A total of 947 (62%) patients from the ECCO-EpiCom inception
cohort—217 (23%) from Eastern Europe and 730 (77%) from
Western Europe—answered the quality of care questionnaire
during a median time interval of 14 months after inclusion in
the study (range: 0–24 months). The number of included
patients from each participating country is shown in Table 1.
The reasons for 38% of the patients did not answer the
questionnaire were as follows: lost to follow-up (148), did not
give consent or refused to answer (421). Patient characteris-
tics (Table 2) did not differ between Eastern and Western
European countries except for diagnosis and educational
status.
3.1. Time interval between the onset of symptoms
and diagnosis
In Eastern Europe, significantly more patients were diag-
nosed within 6 months of onset of symptoms compared to
Western Europe (77% vs. 59%, p b 0.05), while in Western
Europe significantly more patients were diagnosed between
6 and 12 months and after 1 year (16% vs. 10%, p b 0.05 and
25% vs. 13%, p b 0.05). The diagnosis-specific time interval
between the onset of symptoms and the diagnosis is
illustrated in Fig. 1. The time elapsed between the first
consultation with the general practitioner and referral to an
IBD specialist was similar in both geographic regions, with
most of the patients assigned to a specialist within 3 months
of their first visit to the general practitioner (east: 70% vs.
west: 65%, p = 0.26).
3.2. Information
In total, 77% of the patients from both regions did not have any
knowledge about IBD before the diagnosis was established
(east: 77% vs. west: 76%, p = 0.93).
The sources of the information about IBD in the health care
system are illustrated in Fig. 2. The received information
Table 1 Number of patients from each participating country
of the ECCO-EpiCom 2010 inception cohort answering the
ECCO-EpiCom QoC questionnaire.
Eastern European countries Number of included patients
Croatia 12
Czech Republic 43
Estonia 21
Hungary 50
Lithuania 31
Moldova 10
Romania 24
Russia 26
Western European countries
Denmark 143
Spain 89
Israel 43
Sweden 52
Greece 15
Italy 130
Portugal 29
Finland 40
Cyprus 19
Ireland 23
UK 79
Iceland 30
Greenland 7
Faroe Islands 31
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 was considered “good” by the majority of patients in both
regions (east: 86% vs. west: 84%, p = 0.54). In Eastern Europe,
significantly more patients searched for additional information
regarding their disease independently (77% vs. 68%, p b 0.05);
the sources of such information are presented in Fig. 3.
Differences in evaluating the current status of information are
shown in Table 3.une 3, 20163.3. Education
In Eastern European countries, 77% of the patients received
IBD-related education compared toWestern Europe,where only
41% of the responders were educated concerning their disease
(p b 0.05). Differences between sources of disease-related
education are shown in Table 4.
In Western Europe, significantly more patients felt able
to consult a nurse regarding their IBD questions (21% vs. 3%,
p b 0.05).3.4. Empathy
Two hundred and four (94%) patients from Eastern Europe and
522 (72%) from Western Europe stated that their doctor
indicated interest in how IBD impacts their quality of life
(p b 0.05). In Eastern Europe, significantly fewer patients
identified the nurses and secretaries as the category of health
care providers showing “appropriate courtesy” compared to
Western Europe (54% vs. 77%, p b 0.05 and 29% vs. 54%,p b 0.05), but in the case of doctors, there was no difference
observed (east: 89% vs. west: 87%, p = 0.41).
3.5. Access to health care providers
In Eastern Europe, gastroenterologists were significantly easier
to contact by the patients (80% vs. 68%, p b 0.05). In Western
Europe, other members of the IBD staff were more in the
forefront, i.e., nurses (57% vs. 47%, p b 0.05) and secretaries
(41% vs. 29%, p b 0.05).
4. Discussion
Wepresent here for the first time differences in health care and
patient education between Eastern and Western European
countries in a population-based prospectively diagnosed incep-
tion cohort of IBD patients. In this study, one of the most
important findings was the difference in the structure of the IBD
staff: in Eastern Europe, the IBD specialist was the only source
of disease-related education—contrary to Western Europe,
where patients also obtained education and information from
an IBD nurse. However, the level of satisfaction felt by patients
regarding such IBD information was high in both Eastern and
Western Europe.
In this study, significantly more patients in the Eastern
European countries received IBD-related education compared
toWestern European countries. However, it is important to take
into consideration that the item regarding education in the QoC
questionnaire could be interpreted by the patients in different
ways. In some hospitals, there are special education programs
for IBD patients mostly managed by IBD nurses, which include
both oral and video presentations about the development of the
disease, medication, nutrition and how patients might be able
to cope better with their condition. In countries where these
special education programs are not available, patients
are educated about their disease by their IBD specialist at
the follow-up visits in the outpatient clinic. This difference is
clearly observable in the item regarding sources of education
about IBD; in Western Europe, significantly more patients chose
nurses. IBD-related education plays an important role in
patients' management, insight into the pathogenesis of IBD
and understanding the importance of therapy, which subse-
quently might improve patients' compliance,10 satisfaction11
and coping strategies.12
In Western Europe, significantly more patients could turn to
a nurse regarding their IBD questions. With an increasing
number of IBD patients, specialist nurses have become much
more involved in the management of the disease.13 In countries
where an IBD nurse network exists beside the IBD specialist,
patients are increasingly educated about their disease and
medication by them. Often, a telephone helpline service
managed by the IBD nurse provides an immediate access for
the patients. However, in countries where nurses do not provide
the same support, i.e., in all Eastern European countries, the
gastroenterologists are the only source of IBD-related education
among the health care providers.
There are few studies investigating the impact of IBD nurse
care on patients' HRQoL and disease outcomes. In a review of
Belling et al.,14 one randomized controlled trial was included
comparing a specialist nurse-led counseling service with routine
outpatient clinic follow-ups, investigating their effect on HRQoL
Table 2 Characteristics of incident patients with inflammatory bowel disease from the ECCO-EpiCom inception cohort
answering the quality of care questionnaire.
Western European centers Eastern European centers
CD UC IBDU CD UC IBDU
No of patients (n (%))* 276 (38) 361 (50) 93 (12) 87 (40) 124 (57) 6 (3)
Males (n (%)) 145 (53) 207 (57) 44 (47) 50 (57) 69 (56) 4 (67)
Age at diagnosis (years) Median (range) 37 (16–89) 40 (15–89) 39 (17–77) 31 (15–78) 35 (18–80) 30 (20–34)
Time from symptoms to diagnosis (months)
Median (range)
4
(0–31 years)
2.3
(0–21 years)
2.3
(0–30 years)
3.4
(0–10 years)
2.3
(0–20 years)
2.7
(0–3 years)
Location at diagnosis (n (%))
Ileal ± upper disease 90 (33) 37 (43)
Colonic ± upper disease 86 (31) 21 (24)
Ileocolonic ± upper disease 73 (27) 27 (31)
Isolated upper disease 23 (8) 1 (1)
Missing** 4 (1) 1 (1)
Behavior at diagnosis (n (%))
Non-stricturing, non-penetrating ±
perianal disease
174 (63) 58 (67)
Stricturing ± perianal disease 63 (23) 17 (19)
Penetrating ± perianal disease 39 (14) 12 (14)
Extent at diagnosis (n (%))
Proctitis 67 (19) 24 (19)
Left-sided 149 (41) 56 (45)
Extensive colitis 145 (40) 44 (36)
Smoking status (n (%))
Never smoker 111 (41) 183 (53) 44 (51) 30 (35) 67 (54) 4 (67)
Currently smoker 95 (35) 27 (8) 10 (11) 32 (37) 12 (10) 2 (33)
Former smoker 66 (24) 135 (39) 33 (38) 24 (28) 45 (36) 0 (0)
Educational status (n (%))*
Completed academic education 63 (23) 70 (21) 16 (19) 14 (16) 36 (29) 0 (0)
Completed non-academic education 149 (55) 191 (57) 45 (53) 48 (56) 57 (46) 6 (100)
Currently in education 35 (13) 39 (12) 7 (8) 20 (23) 25 (20) 0 (0)
No education 23 (9) 35 (10) 17 (20) 4 (5) 6 (5) 0 (0)
Employment status (n (%))
Employed 142 (52) 183 (54) 48 (55) 43 (50) 70 (56) 5 (83)
Self-employed 15 (6) 25 (7) 6 (7) 4 (5) 5 (4) 0 (0)
Unemployed 42 (15) 30 (9) 10 (12) 14 (16) 5 (4) 1 (17)
Student 40 (15) 45 (13) 10 (12) 17 (20) 22 (18) 0 (0)
Retired 33 (12) 59 (17) 12 (14) 8 (9) 22 (18) 0 (0)
*p b 0.05; p values are given for comparison between Eastern and Western Europe.
**Diagnosis was made during surgery.
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 in IBD patients. Pooledmeanmental health scores seemed to be
higher in patients who received nurse-led counseling, although
this difference was not statistically significant (WMD 3.67; 95%
CI = −0.44 to 7.77; p = 0.08). However, this finding is difficult
to interpret due to the risk of recruitment bias and small sample
size. In a randomized trial of Jelsness-Jorgensen et al.,15 there
were no differences regarding quality of life, worries, frequency
of relapse, sick leave, hospitalization or surgery between the
nurse- and gastroenterologist-led group after a 1-year follow-up
period, but the participants of the nurse-led group experienced
a significantly shorter time interval from the start of relapse to
the start of treatment. In the study of Bager et al.,16 IBD
patients were asked about whether they would like to change
regular follow-up visits to annual blood sample collections
followed by a telephone call from an IBD nurse and 87% of the
patients agreed to adopt the self-management approach.
Themain source of IBD information in the health care system
was the hospital doctor in both geographic regions. In EasternEurope, significantly more patients sought out information
about IBD independently; the main source in both regions was
the Internet. In the study by Politi et al.,17 patients from the
European collaborative study on inflammatory bowel disease
cohort were asked about their preferences for communication
of information. Similar to our study, 65.5% of the patients got
information from the specialist, and 77% of the patients were
satisfied with their current amount of information. In total,
24.6% of the patients reported the Internet, as their current
source of information, while in our study this proportion was
much higher, at 64% of all patients. In the last decade, the
spread of online research could be one of the important factors
in increasing the awareness of IBD and consequently in
shortening the time interval between the onset of symptoms
and diagnosis. A cross-cultural variation regarding IBD knowl-
edge was investigated in the study of Blumenstein et al.18
between German and Irish IBD patients. They found few
differences between the two geographic regions, although
(a) Eastern Europe
(b) Western Europe
Figure 1 Diagnosis-specific time interval between the onset
of symptoms and diagnosis of patients with inflammatory bowel
disease (a) in Eastern Europe and (b) in Western Europe.
Figure 3 Patients' sources of additional information about
inflammatory bowel disease. Booklets: booklets from patients'
organization; others: relatives, friends, newspaper.
816 J. Burisch et al.
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 German patients obtained knowledge from a wider range of
sources compared to Irish patients, most notably from the
Internet (p b 0.001).
Several limitations in this study need to be taken into
consideration. First, the perception of QoC may vary within
and between different geographic regions. Thus, patients
might perceive the quality of the health care service and
their health status in a different way. There is also a marked
difference in the local health care systems throughout
Europe regarding insurance systems, budgetary restrictions,
education and access to health care providers.4 Further-
more, of the original ECCO-EpiCom cohort of 1,515 patients,Figure 2 Patients' sources of information about inflammatory
bowel disease in the health care system. GP: general practitioner.only 62% answered the questionnaire. However, these
patients did not differ from the whole cohort in terms of
patient characteristics. Comparing the responder patients to
those who did not answer the questionnaire, we found
differences in diagnosis (CD: 38% vs. 30%, UC: 51% vs. 58%),
extent of UC (proctitis: 19% vs. 23%, extensive colitis: 39%
vs. 34%), smoking status (never: 48% vs. 54%, former: 33%
vs. 25%) and educational status (academic: 22% vs. 12%,
currently in education: 14% vs. 22%, no education: 9% vs.
15%). The low response rate could be explained by several
reasons. If patients were not able to answer the question-
naire by themselves, the doctor or IBD nurse completed the
questionnaire together with the patient and this could have
either made patients decline answering the questionnaire or
introduced bias in the results as patients could have felt
uncomfortable when responding to questions regarding
satisfaction and courtesy. Also, this questionnaire has not
been validated or properly been forward/backward trans-
lated into languages other than English, which might have
been a barrier for some patients. Although, a questionnaire
on QoC was available from the former EC-IBD group,19 it was
decided by the EpiCom study group at study initiation to use
a new questionnaire created by IBD nurses that better fitted
the needs of this study. The QUOTE-IBD questionnaire was
constructed to evaluate the QoC from patients' aspect, while
the QoC questionnaire was developed from IBD nurses'
perspective and experience from everyday practice. In the
future, it is essential that EpiCom further validates and
develops the QoC questionnaire.
In conclusion, in this study, we present novel data on
differences in health care and education between EasternTable 3 Patients' level of satisfaction with their current
amount of information about inflammatory bowel disease.
East
n (%)
West
n (%)
p-value
Not at all 4 (2) 17 (2) 0.87
So and so 34 (16) 90 (13) 0.24
Enough 44 (21) 200 (28) 0.04
Quite 93 (44) 226 (32) b0.01
Very much 36 (17) 178 (25) 0.02
Table 4 Patients' sources of education about
inflammatory bowel disease.
East
n (%)
West
n (%)
p-value
General practitioner 31 (19) 25 (8) b0.01
IBD staff at hospital 114 (69) 209 (70) 0.86
Patient organization 6 (4) 11 (4) 1.00
Other 6 (4) 13 (5) 0.89
Gastroenterologist 50 (30) 87 (29) 0.90
Nurse 1 (1) 56 (19) b0.01
Secretary 0 (0) 0 (0) —
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 and Western Europe from the IBD patient's perspective. We
found differences in each investigated aspect of the health
care system, but patients' level of satisfaction with the
received information about their disease was high in both
geographic regions. The main difference was found in the
structure of the IBD staff as IBD nurses take part in patients'
education in Western Europe, while the gastroenterologist in
Eastern Europe is the only source of professional knowledge
about IBD among health care providers. The increasing
number of IBD patients and the chronicity of the diseases
underscore the need for optimization of QoC in Europe,
where regional differences in health care systems and
possibly in the perception of QoC need to be taken into
consideration.
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.crohns.2013.12.023.
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